| Dr Franklin David Rudnick, MD | |
|
501 Santa Monica Blvd, Suite 509, Santa Monica, CA 90401-2431 | |
| (310) 393-5433 | |
| (310) 587-9221 |
| Full Name | Dr Franklin David Rudnick |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 48 Years |
| Location | 501 Santa Monica Blvd, Santa Monica, California |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043351000 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | G34733 (California) | Primary |
| Entity Name | F. David Rudnick, Md, A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427329028 PECOS PAC ID: 9335316751 Enrollment ID: O20120125000308 |
News Archive
Sigma Life Science, the innovative biological products and services brand of Sigma-Aldrich, today introduced the world's first p53 'knockout' rat model, an important development that is expected to, due to the rat's closer physiological and metabolic similarity to humans, significantly improve timelines for carcinogenicity screening and reduce time to market for therapeutics.
In Florida, there are more than 540,000 people living with Alzheimer's disease (AD), the most recognized form of dementia. The number of people in Florida who are age 65 and older with AD is expected to increase 41.2 percent by 2025 to a projected 720,000, highlighting the urgency of finding medical and treatment breakthroughs.
Biocept, Inc., a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, announces that Columbia University Medical Center will conduct a study to evaluate the clinical utility of the Company's Target Selector™ platform to diagnose leptomeningeal metastases (LM) in patients with breast cancer.
Kibow Biotech, Inc. today announced that it has renewed its exclusive worldwide licensing and marketing agreement with the current licensing partner specializing in animal health.
Although there is currently no treatment approved by the Federal Drug Administration (FDA) for acute attacks of hereditary angioedema (HAE) - a genetic disease causing swelling of extremities, face and internal organs that can be life-threatening - hope is on the horizon according to a team of experts presenting the latest research at the Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Dallas.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Franklin David Rudnick, MD 501 Santa Monica Blvd, Suite 509, Santa Monica, CA 90401-2431 Ph: (310) 393-5433 | Dr Franklin David Rudnick, MD 501 Santa Monica Blvd, Suite 509, Santa Monica, CA 90401-2431 Ph: (310) 393-5433 |
News Archive
Sigma Life Science, the innovative biological products and services brand of Sigma-Aldrich, today introduced the world's first p53 'knockout' rat model, an important development that is expected to, due to the rat's closer physiological and metabolic similarity to humans, significantly improve timelines for carcinogenicity screening and reduce time to market for therapeutics.
In Florida, there are more than 540,000 people living with Alzheimer's disease (AD), the most recognized form of dementia. The number of people in Florida who are age 65 and older with AD is expected to increase 41.2 percent by 2025 to a projected 720,000, highlighting the urgency of finding medical and treatment breakthroughs.
Biocept, Inc., a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, announces that Columbia University Medical Center will conduct a study to evaluate the clinical utility of the Company's Target Selector™ platform to diagnose leptomeningeal metastases (LM) in patients with breast cancer.
Kibow Biotech, Inc. today announced that it has renewed its exclusive worldwide licensing and marketing agreement with the current licensing partner specializing in animal health.
Although there is currently no treatment approved by the Federal Drug Administration (FDA) for acute attacks of hereditary angioedema (HAE) - a genetic disease causing swelling of extremities, face and internal organs that can be life-threatening - hope is on the horizon according to a team of experts presenting the latest research at the Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Dallas.
› Verified 1 days ago
Dr. Michael Gong-ruey Ho, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1801 Wilshire Blvd Ste 100, Santa Monica, CA 90403 Phone: 310-319-5098 | |
Jill K. Smith, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2730 Wilshire Blvd, Suite 660, Santa Monica, CA 90403 Phone: 310-453-9100 Fax: 310-453-1155 | |
Dr. Robert Logan James, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3201 Wilshire Blvd, 306, Santa Monica, CA 90403 Phone: 310-828-6680 Fax: 310-829-5196 | |
Dr. Stacy A Cohen, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2730 Wilshire Blvd. #350, Santa Monica, CA 90403 Phone: 424-532-1552 Fax: 888-247-7249 | |
Dr. Lana Mae Benedek, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 900 Wilshire Blvd, Suite 314, Santa Monica, CA 90401 Phone: 310-395-0077 Fax: 310-395-9977 | |
Salm Robert Moradi, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3201 Wilshire Blvd, Suite# 209, Santa Monica, CA 90403 Phone: 310-829-1404 Fax: 310-829-1406 |